JP Morgan Reiterates Neutral on Johnson & Johnson

JP Morgan maintains its Neutral rating on Johnson & Johnson JNJ as the company reported fourth quarter results and guided below consensus for 2012. JP Morgan notes, "J&J issued 2012 EPS guidance of $5.05-$5.15, which compares to the Street consensus of $5.22. This is consistent with our view heading into the guide that Street numbers for J&J were too high, with the company likely to guide $0.10-$0.15 below consensus. The guidance range compares to our $5.10, but its worth noting that our model includes $0.05 dilution from Synthes – guidance does not – so we are on an adjusted basis at the upper end of the range (assuming Synthes moves the guidance down $0.05). Top-line guidance calls for organic sales growth of 3.5-5.5% (vs our 5.0%), offset by a 250bp Fx headwind." JNJ closed at $65 a share on Monday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorReiterationAnalyst RatingsJP Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!